Monument Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$947K Sell
2,614
-52
-2% -$17.8K 0.19% 115
2026
Q1
$938K Sell
2,666
-122
-4% -$43.5K 0.24% 100
2025
Q4
$913K Buy
2,788
+1,412
+103% +$448K 0.23% 100
2025
Q3
$388K Sell
1,376
-62
-4% -$18K 0.1% 153
2025
Q2
$401K Sell
1,438
-182
-11% -$51.6K 0.1% 142
2025
Q1
$505K Sell
1,620
-123
-7% -$36.3K 0.16% 116
2024
Q4
$454K Sell
1,743
-359
-17% -$107K 0.13% 123
2024
Q3
$677K Buy
2,102
+43
+2% +$14.1K 0.19% 93
2024
Q2
$643K Sell
2,059
-101
-5% -$29.7K 0.19% 92
2024
Q1
$614K Sell
2,160
-76
-3% -$22.2K 0.18% 102
2023
Q4
$644K Buy
2,236
+66
+3% +$18K 0.21% 100
2023
Q3
$583K Buy
2,170
+687
+46% +$171K 0.2% 94
2023
Q2
$329K Sell
1,483
-844
-36% -$196K 0.11% 128
2023
Q1
$563K Buy
2,327
+83
+4% +$20.4K 0.19% 90
2022
Q4
$589K Buy
2,244
+880
+65% +$236K 0.2% 91
2022
Q3
$308K Buy
1,364
+128
+10% +$31K 0.12% 122
2022
Q2
$301K Buy
+1,236
New +$303K 0.11% 118
2021
Q4
Sell
-2,362
Closed -$502K 143
2021
Q3
$502K Buy
2,362
+86
+4% +$19.8K 0.17% 105
2021
Q2
$555K Buy
+2,276
New +$560K 0.19% 94
2021
Q1
Sell
-9,548
Closed -$2.19M 108
2020
Q4
$2.19M Buy
9,548
+743
+8% +$171K 1.01% 53
2020
Q3
$2.24M Buy
8,805
+264
+3% +$65.4K 1.18% 43
2020
Q2
$2.01M Sell
8,541
-92
-1% -$21K 1.18% 40
2020
Q1
$1.75M Buy
8,633
+341
+4% +$74.5K 1.26% 41
2019
Q4
$2M Buy
8,292
+66
+0.8% +$14.5K 1.02% 50
2019
Q3
$1.59M Sell
8,226
-204
-2% -$39.2K 0.86% 54
2019
Q2
$1.57M Buy
+8,430
New +$1.51M 0.85% 54
2018
Q4
Sell
-13
Closed -$3K 100
2018
Q3
$3K Buy
+13
New +$2.56K ﹤0.01% 208

Other funds holding AMGN

Monument Capital Management's AMGN Position: Q2 2026 in Review

Monument Capital Management reduced its Amgen (AMGN) stake by 2% in Q2 2026, selling an estimated $17.8K and leaving 2,614 shares worth $947K. The position accounts for 0.19% of the portfolio, ranked #115.

Monument Capital Management first reported a position in AMGN in Q3 2018 and has held it in 27 quarters since. The position peaked at $2.24M in Q3 2020. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Monument Capital Management held 2,614 shares of Amgen worth $947K as of Q2 2026.
  • Monument Capital Management sold 52 Amgen shares in Q2 2026, an estimated $17.8K.
  • Amgen made up 0.19% of Monument Capital Management's portfolio in Q2 2026, its #115 holding.
  • Monument Capital Management first reported a position in Amgen in Q3 2018 and has held it in 27 quarters since.
  • Monument Capital Management's Amgen position peaked at $2.24M in Q3 2020.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Monument Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.